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BlastocystEarly lineage segregation in mouse development results in two, either CDX2- or OCT4/NANOG-positive, cell
populations. CDX2-positive cells form the trophectoderm (TE), OCT4/NANOG-positive cells the inner cell
mass (ICM). In a second lineage decision ICM cells segregate into Epiblast (EPI) and primitive endoderm
(PE). EPI and PE formation depend on the activity of the transcription factors Nanog and Gata4/6. A role for
Nanog, a crucial pluripotency factor, in preventing PE differentiation has been proposed, as outgrowths of
mutant ICMs result in PE, but not EPI derivatives. We established Nanog-mutant mouse lines and analyzed
EPI and PE formation in vivo. Surprisingly, Gata4 expression in mutant ICM cells is absent or strongly
decreased, thus loss of Nanog does not result in precocious endoderm differentiation. However, Nanog-
deﬁcient embryos retain the capacity to form PE in chimeric embryos and, in contrast to recent reports, in
blastocyst outgrowths. Based on our ﬁndings we propose a non-cell autonomous requirement of Nanog for
proper PE formation in addition to its essential role in EPI determination.esserschmidt).
ll rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
The ﬁrst lineage segregations in the pre-implantation embryo
establish the basis for mouse embryonic development. At the compact-
ing morula stage, trophectoderm (TE) and inner cell mass (ICM)
emerge; later the ICMgives rise to primitive endoderm(PE) andepiblast
(EPI) (Gardner and Beddington, 1988). Recent evidence suggests that
unlike TE/ICM segregation in the morula (Ralston and Rossant, 2008),
lineage-speciﬁc gene expression precedes EPI- and PE-cell sorting in the
ICM. Before the PE becomes evident, the ICM is already composed of
two, committed cell types arranged in a ‘salt-and-pepper-like’ distribu-
tion (Chazaud et al., 2006). Transcription factors determine the adopted
fate: PE cells express Gata6 and Gata4 (Koutsourakis et al., 1999;
Morrisey et al., 1998), and EPI cells the homeobox transcription factor
Nanog (Chambers et al., 2003; Mitsui et al., 2003). Nanog expression
commences at themorula stage and becomes gradually restricted to the
ICMduringblastocyst formation and expansion (Hart et al., 2004;Mitsui
et al., 2003; Zernicka-Goetz et al., 2009). Disruption of Nanog results in
peri-implantation lethality and although mutant blastocysts are
morphologically normal and induce decidualization they don't form a
proper EPI. Embryonic stem (ES) cells cannot be isolated from Nanog-
deﬁcient blastocysts; the cells recovered from blastocyst outgrowths
display a parietal endoderm-like morphology (Mitsui et al., 2003).
Gata4/6-deﬁcient embryos show deﬁcits in establishing PE and fail tomaintain PE derivatives (Koutsourakis et al., 1999;Morrisey et al., 1998;
Soudais et al., 1995), while over-expression of Gata4/6 in ES cells is
sufﬁcient to induce PE differentiation (Fujikura et al., 2002). A direct link
betweenNanogandGata6wasproposedandNANOGwas shown tobind
the Gata6 promoter in ES cells (Mitsui et al., 2003; Singh et al., 2007).
While early knock-out studies reported endodermal differentia-
tion of Nanog-mutant ICMs, a recent study addressing the role of
Nanog in the generation of pluripotency suggested thatNanog-mutant
ICM cells are blocked in a transitional stage and are not capable of
acquiring the pluripotent ground state and lose their differentiation
potential (Silva et al., 2009). These authors propose that Nanog-null
ICM cells are thus only capable of TE differentiation or else undergo
apoptosis, as opposed to the original description of PE outgrowth
(Mitsui et al., 2003).
We established and examined Nanog gene-trap mouse lines and
found that surprisingly PE formation inmutant blastocysts is profoundly
repressed rather than precociously activated. However, in this studywe
took the analysis from Nanog mutants further, showing that surviving
ICM cells from Nanog-null embryos retain the capacity for PE formation
in vivo and at least transiently in vitro. Thus, ourﬁndings help resolve the
recently emerged controversy of Nanog action in the early mouse
embryo (Mitsui et al., 2003; Silva et al., 2009), and moreover, we
demonstrate that PE formation depends on a functional EPI, hence
directly or indirectly, on Nanog expression. In the model we propose,
Nanog expression is required for the formation of the EPI lineage, which
in turn through a non-cell autonomous mechanism, possibly mediated
by FGF/Erk signaling (Chazaud et al., 2006; Nichols et al., 2009), is vital
for proper PE formation.
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Generation of gene-trap mice and genotyping
Two ES cell lines (D042B07 [GT1] and D047A12 [GT2]) with
disrupted Nanog alleles were obtained from the GSF (Munich)
(Schnutgen et al., 2005) (Supplementary Fig. S1) and used for blastocyst
injection. Chimeras were mated with C57BL/6 females to generate the
Nanoggt1/+ and Nanoggt2/+ mouse lines. Genotyping was performed by
PCR on genomic DNA isolated from embryos, yolk sacs or mouse-tail
biopsies using primers speciﬁc for the GT1- or GT2-allele. For blastocyst
complementation the Gt(Rosa)26Sor/J (ROSA26) line (Zambrowicz
et al., 1997) was bred onto the GT1-Nanog background and matings
performed as detailed in supplementary Fig. S2.
Whole-mount immunodetection
Embryos were ﬂushed (E3.5) or dissected (E4.5) from the uterus
followingnaturalmatings, countingnoonof theday theplugwasdetected
as E0.5. Antibody detection assays were performed as described in (Kan
et al., 2007). Self-made afﬁnity-puriﬁed rabbit antibody for NANOG was
used at a dilution of 1:50, OCT4 (monoclonal mouse, Santa Cruz
Biotechnology) at 1:200, CDX2 (monoclonal mouse, BioGenex) at 1:200
and GATA4 (polyclonal rabbit, Santa Cruz Biotechnology) at 1:100.
Secondary antibodies used were Alexa Fluor 488 goat anti-rabbit and
Alexa Fluor 594 goat anti-mouse (Molecular Probes; 1:500). Nuclei were
stained with 10 µM DAPI (Molecular Probes) added to the last wash. For
double staining of blastocyst outgrowths with GATA4 an additional α-
NANOG antibody (R&D, polyclonal goat, 1:10) was used.
ES cell culture, blastocyst outgrowths and embryo culture
ES cells were cultured on feeder cells in ES cell medium (DMEMwith
15% FCS, supplementedwith 500 U/ml LIF [Chemicon, ESGRO#ES1107]).
Forblastocyst outgrowths embryoswere recoveredat E3.5 andcultured in
ES cell medium on gelatinized tissue culture chambers (Lab-tek
#177402). After 5 days, attached outgrowths were ﬁxed in 4% PFA/PBS,
permeabilized in 0.5% Triton X-100/PBS and blocked in 10% FCS in 0.1%
Triton X-100/PBS (PBSTx). First and second antibody incubation was
performed in blocking solution as described above. Embryos were
cultured in KSOM microdrops covered with mineral oil at 37 °C and 5%
CO2 atmosphere. Inhibitor treatment on wild-type embryos was
performed in KSOM microdrops containing 20 µM SU5402 in DMSO or
DSMO only for controls. FGF treatment was performed on embryos from
heterozygous intercrosses isolated at E2.5 and cultured for 48 in the
presence of human recombinant FGF4 (10−8 M; Sigma) in KSOM
microdrops. Blastocysts were PCR genotyped after GATA4 immuno-
staining.
Generation and analysis of chimeric embryos
Wild-typeW4 or stable pCAGGS-eGFP transfectedW4 ES cells were
injected into E3.5 blastocysts obtained from matings according to
supplementary Fig. S2. All embryos resulting from thesematings carry a
ubiquitously expressed β-galactosidase reporter, allowing tracing of
embryo-derived cells. After ES cell-injection the blastocysts were
retransferred into pseudo-pregnant females and embryos isolated at
indicated time points. LacZ staining was performed as described
previously (Stemmler et al., 2005). For IF, embryos and yolk sacs were
frozen in OCT (Tissue-tek) and sectioned at 14 µm using a cryostat
(Leica). Sectionswere blocked in 10% FCS/PBSTx and incubatedwithα-
GFP (polyclonal sheep, 1:400; AbD) and α-β-galactosidase (polyclonal
rabbit, 1:1000; MPBiomedicals) antibodies for 1 h at RT. GFP was
visualized with biotin-conjugated donkey-anti-sheep Ig (Jackson Labs;
1:300) and FITC-conjugated streptavidin (Jackson Labs; 1:400); β-GAL
with Cy3-conjugated donkey-anti-rabbit Ig (Jackson Labs; 1:300).Results and discussion
Nanog gene-trap embryos
Despite the relatively early expression of Nanog in pre-implantation
embryos,Nanogmutants formnormalmorulae,whichcompact andgive
rise to morphologically normal blastocysts (Hart et al., 2004; Mitsui
et al., 2003). We established two independent gene-trap mouse lines
carrying a β-Geo insertion in the ﬁrst intron of the Nanog locus
(Supplementary Fig. S1A, B). We ﬁrst investigated homozygous
offspring of both lines for NANOG expression and found that embryos
homozygous for either allele (Nanoggt1/gt1 or Nanoggt2/gt2) failed to
express NANOG at pre-implantation stages (supplementary Fig. S1C).
We failed to derive live homozygous offspring from either gene-trap
line, and did not succeed in isolating homozygous mutants at E7.5,
whereas phenotypically undistinguishable heterozygous and wild-type
embryos were present. The number of empty deciduomas found,
matched the expectedMendelian ratio of 25%. Thus, we concluded that,
although genetically different in terms of the gene-trap integration site
within the ﬁrst intron, both, Nanoggt1/gt1 and Nanoggt2/gt2 embryos
phenocopied the previously describedNanog-null mutant (Mitsui et al.,
2003) and have identical phenotypes. Further, blastocysts carrying both
gene-trap alleles (Nanoggt1/gt2) were indistinguishable from homozy-
gous embryos for either allele (Nanoggt1/gt1 or Nanoggt2/gt2) (Fig. 1 A, G
and supplementary Fig. S1C). All breeding for experiments shown was
carried out using intercrosses of both strains allowing accurate
identiﬁcation of null-mutants by PCR. Thus, embryos carrying both
disrupted alleles are referred to as ‘mutants’, and heterozygous and
wild-type embryos are grouped as ‘controls’.
TE/ICM lineage segregation is independent of Nanog
We analyzed TE and ICM formation by examining expression of the
TE-marker CDX2 and the ICM-marker OCT4 in mutant and control E3.5
blastocysts. CDX2 was restricted to the nuclei of the TE cells in both
mutants (Figs. 1A–C) and controls (Figs. 1D–F). Though NANOG was
absent in the mutants, we did not ﬁnd CDX2 in ICM cells as has been
described recently (Chen et al., 2009). OCT4was detectable in all cells of
the early blastocyst stage (Figs. 1H, K), thus CDX2 expression does not
inevitably drive Oct4 repression in vivo. Only later at implantation does
OCT4 become restricted to the ICM (Dietrich and Hiiragi, 2007). Oct4
expression, however,was unaffected by the loss ofNanog (Figs. 1G–I). To
ascertain whether loss of Nanog affects cell proliferation, we counted TE
and ICM cells in mutant and control blastocysts on stacks of confocal z-
series images of CDX2/DAPI stained blastocysts (Fig. 1M). CDX2-positive
cells were subtracted from the total cell number to determine the
number of ICM cells. Mutant embryos were compared to their control
littermates to assure stage/age-matched blastocysts. In one litter ICM
cell numbers were 20.3±2.1 (standard deviation, sd) inmutant (n=3)
and 22.3±3.9 (sd) in control embryos (n=9). TE cell numbers were
32.3±2.3 (sd) in mutants and 30.1±2.4 (sd) in controls. Therefore, we
didnotﬁnd signiﬁcantdifferences in thenumberof ICM(Student's t-test,
p=0.3) or TE (p=0.23) cells in mutants and controls. In a second litter
ICM cell numberswere 24 (mutant, n=1) and 24.5±1.9 (sd) (controls,
n=8) and TE cell numbers were 32 (mutant) and 33±5.5 (sd)
(control). We concluded that, whilst Nanog is expressed at the morula
stage, it is neither required for segregation of TE and ICM, nor for cell
proliferation until the E3.5 blastocyst stage.
Nanog mutant ICMs show defects at implantation
The same marker-gene analysis was conducted on implanting
embryos (E4.5), which were directly dissected from the uterus. All
embryos had hatched and attached to the uterine wall at the time of
isolation. In control embryos NANOG-positive and NANOG-negative
ICM cells were distinct populations (Figs. 2E, H), whereas at E3.5 they
Fig. 1. IF detection of NANOG (A, D, G, J), CDX2 (B, E) and OCT4 (H, K) in E3.5 Nanog-mutant (A–C, G–I) and control (D–F, J–L) blastocysts. NANOG-positive cells (yellow arrowheads)
are intermingled with future PE cells (white arrowheads). Delineated areas (A–F) mark the ICM devoid of CDX2. (C, F, I, L) Merged images. (M) Quantiﬁcation of ICM cells in mutant
and control E3.5 blastocysts. Numbers of embryos are indicated in each bar. ICM cell numbers are not signiﬁcantly reduced in mutants (Student's t-test, #p=0.3). (Scale bars:
50 μm).
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and white arrowheads). OCT4 was absent in most TE cells in E4.5
embryos and the ICM expression domain was divided into two
populations in controls, either overlapping with NANOG (Figs. 2E, H,
outlined area) or GATA4 (Fig. 3L). The Nanog-deﬁcient E4.5 embryos
were comparable in size to their littermates and had implanted,
indicating normal development. In mutants, all ICM cells expressed
OCT4, however, the number of ICM cells appeared to be reduced
(Figs. 2B, D). We observed frequent pyknotic and fragmented nuclei in
mutant embryos, indicating apoptosis (Fig. 2C, red arrowheads). This
was conﬁrmed by the high incidence of active Caspase3 positive cells in
mutant embryos isolated at E4.5 (Fig. 2I, red arrowhead). In contrast we
observed few active Caspase3 positive cells in controls at the examined
implantation stage (Fig. 2K). We conﬁrmed our observation by
examining additional E4.5 embryos isolated from C57BL/6 wild-typeFig. 2. IF detection of NANOG (A, E) and OCT4 (B, F) in Nanog-mutant and control E4.5 emb
delineated area) but absent in the PE. OCT4 expression is absent in the TE, but present in mu
and pyknotic nuclei detectable in the mutant (C), but not in control ICMs (G). (D, H) Overlay
cells are detectable in the mutant (I, J; red arrowheads) but not in the control (K, L). (M) Qu
each bar. Cell numbers are highly signiﬁcantly reduced in mutant embryos (Student's t-tesmice. In two litters, containing 12 and 10 implanted embryos we found
only two embryos each containing a single active Caspase3 positive cell
localized to the ICM in one, and to the TE in the other embryo. At this
stage the PE endoderm layer is formed and the sorting/migration of EPI
and PE cells is completed (Figs. 2H and 3L). This result is in agreement
with reports documenting decreasing cell death in embryos upon
implantation (Copp, 1978), although apoptotic cells can be readily
detected in wild-type pre-implantation embryos during the sorting
process of EPI and PE cells within the ICM (Meilhac et al., 2009; Plusa
et al., 2008). Additionally, our detection of apoptotic cells by staining for
active Caspase3 reﬂects a ‘snap-shot’ of apoptotic events in the embryos,
rather thanobservationsmade in an extended period of timeduring live
cell imaging (Meilhac et al., 2009; Plusa et al., 2008).
The reduction of ICM cell numbers in Nanog mutants was
quantiﬁed by counting cells in embryos stained for CDX2 (TE) orryos. NANOG is undetectable in the mutant (A), conﬁned to the EPI in the control (E, H,
tant and control ICMs (B, F). (C, G) Red arrowheads indicate DAPI stained, fragmented
of NANOG, OCT4 and DAPI staining. (I–L) Active Caspase3 and DAPI staining; apoptotic
antiﬁcation of ICM cells in mutants and controls. Numbers of embryos are indicated in
t, *p=0.0059). (Scale bars: 50 μm).
Fig. 3. IF localization of GATA4 (A, D, G, J) and OCT4 (B, E, H, K) in Nanog-mutant (A–C, G–I) and control (D–F, J–L) E3.5 (A–F) and E4.5 (G–L) embryos. GATA4-positive cells in the
mutant embryo are indicated (G, white arrowheads). (C, F, I, L) Overlay of GATA4, OCT4 and DAPI staining. (M–F) Blastocyst outgrowths of a Nanog-mutant (MP) and control (Q–T)
blastocyst stained for GATA4 (M, Q), OCT4 (N, R) and Nuclei (O S). (P, S) Overlay of GATA4, OCT4 and DAPI staining. Lineage derivatives are indicated by white (PE), yellow (EPI) and
red arrowheads (TE). (Scale bars: 100 μm).
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signiﬁcant (Student's t-test; p=0.0059) loss of ICM cells in the Nanog
mutants (26.25±0.81 (sd) n=4) compared to controls (35.3±1.52(sd) n=3) (Fig. 2M). Thus, the ﬁrst indications of a Nanog mutant
phenotype become apparent in the ICM at E4.5 when PE and EPI
segregate.
134 D.M. Messerschmidt, R. Kemler / Developmental Biology 344 (2010) 129–137Nanog mutants don't form primitive endoderm
To determine whether Nanog prevents endoderm differentiation
in vivo, we analyzed mutant embryos for expression of the PE-marker
GATA4. Surprisingly, Nanog-null-mutants did not display precocious
PE marker-gene expression as expected (Mitsui et al., 2003), but were
entirely devoid of Gata4-expressing cells (Fig. 3A), whereas single
GATA4-positive cells could be observed in control ICMs at E3.5
(Fig. 3D). This lack of Gata4 expression raised the possibility of a
Nanog requirement for PE formation.
In E4.5 control embryos the PEwas visible as a discrete structure lining
the ICM towards the blastocoel (Fig. 3J). Nine of 41 embryos stained for
Gata4were identiﬁed asmutants by PCR. Their ICMwas disarranged; a PE
layer was not recognizable. Only three of these embryos contained few
(four or less) GATA4-positive cells (Fig. 3G, white arrowheads). The other
sixmutant embryosdidnot expressGATA4. This observation supports our
hypothesis ofNanog requirement for proper PE formation, but also shows
that this requirement is likely not cell autonomous, because Gata4-
expression can occur in mutant cells.
It has previously been reported that, when cultured in vitro, Nanog-
deﬁcient ICMs differentiate into cells morphologically resembling
parietal endoderm-like cells, but do not give rise to ES cells (Mitsui
et al., 2003). A recent replication of these experiments disputes these
observations claiming the loss of PE differentiation potential in the
Nanog-mutant outgrowths as well (Silva et al., 2009). We obtained
outgrowths of mutant and control E3.5 embryos and assessed Oct4 and
Gata4 expression and genotypes ﬁve days after plating (Figs. 3M–T).
Three litters, obtained from natural mating by intercrossing both gene-
trap strains yielded 25 blastocysts, whichwere plated in singlewells. 22
blastocysts attached and formed outgrowths. Most control embryos
(15/17) formed large outgrowths consistingof at least threedistinct cell
types: (1) OCT4-positive/GATA4-negative EPI-derived cells; (2) OCT4-
positive/GATA4-positive PE-derived cells; and (3) large OCT4-nega-
tive/GATA4-negative cells, presumptive TE-derived cells (Figs. 3Q–T).
Two control outgrowths lacked the EPI lineage, however still contained
PE cells. In an independent experiment we could show that NANOG
expression never overlapped with GATA4 in controls (Supplementary
Fig. S1D). All outgrowths of the mutant blastocysts (n=5), however,
consisted only of PE-derived cells and presumptive TE derivatives,
lacking the OCT4-positive/GATA4-negative EPI-derived population
(Figs.3 M–P).
In summary, Nanog-deﬁcient E3.5 blastocysts, although not expres-
sing Gata4 in vivo, can give rise to GATA4-positive outgrowths in vitro.
Hence,we corroborate thatNanog is indispensable for the formation of a
functional EPI; however, we also show that it is not required for Gata4
repression and inhibition of PE differentiation in the embryo.
Nanog cell- and non-cell autonomous requirement in the blastocyst
To determine the potential of the mutant ICM cells in PE/EPI
formation and the role of Nanog in this process blastocyst complemen-
tation experiments were performed. Although we had observed Gata4
expression in blastocyst outgrowths previously, the functionality of
such putative PE cells is unclear and can only be properly addressed in
vivo. In the paradigm of blastocyst complementation ES cells do not
contribute to TE or PE when injected into blastocysts, yet they have the
competence to contribute to all EPI-derived tissues (Beddington and
Robertson, 1989). Moreover, ES cells have the capacity to form viable,
fully ES-derived embryos when aggregated with extra-embryonic
tissues (Nagy et al., 1990).We generated chimeric embryos by injecting
wild-type W4 ES cells or GFP-labeled W4 ES cells into E3.5 blastocysts
derived from heterozygous GT1-/GT2-Nanog intercrosses and analyzed
lineage contributions of host and injected cells. β-Galactosidase (β-Gal)
expression from the ROSA26 locus in the host embryos allowed tracing
of blastocyst-derived cells (see supplementary Fig. S2 for mating
scheme). At E7.5 embryos derived from injections into controlblastocysts exhibited the whole range of none to almost exclusive ES
cell contribution to the EPI (not shown). Remarkably, though usually
resorbed at this time point, embryos derived from Nanog-null
blastocysts could also be isolated (Fig. 4B). LacZ staining and sectioning
of these embryos revealed that EPI-derived tissues, such as the
embryonic ectoderm and the embryonic and extra-embryonic meso-
derm, were exclusively ES cell derived, i.e. LacZ-negative (Fig. 4B). This
supports the idea of a cell-autonomous requirement of Nanog for
formation of the EPI lineage, even in a wild-type niche. Conversely, TE-
and PE-derived tissues in the rescued null embryos were LacZ positive,
i.e. host blastocyst-derived. The presence of PE-derived tissues such as
the visceral yolk sac endoderm (Fig. 4B), suggests a Nanog/EPI
requirement for proper PE formation and shows the preserved PE
differentiation potential of Nanog-mutant cells.
Nanog-deﬁcient extra-embryonic tissues can support development
post gastrulation. E10.5 embryos obtained by injecting GFP-expres-
sing ES cells into Nanog-null blastocysts look morphologically normal
and display strong ﬂuorescence in the entire embryo (Figs. 4C, D).
Sections from throughout the embryo were examined for GFP and Β-
GAL by IF (Fig. 4E-E"). With the exception of a few β-GAL-positive/
GFP-negative (embryo-derived) cells in the gut endoderm, all cells of
the embryo proper were GFP-positive, thus ES cell-derived. A possible
minor contribution of the extra-embryonic visceral endoderm to the
deﬁnitive gut endoderm has been shown previously (Kwon et al.,
2008). Conversely, controls showed weaker live GFP ﬂuorescence in
whole embryos due to the chimerism of GFP- or Β-GAL-positive cells,
as shown on the analyzed sections (Figs. 4G–I). Notably, the strong
GFP signal in the heart appears to result from higher activity of the
chicken Β-actin promoter in the heart mesoderm (unpublished
observations). Stained sections of the yolk sac derived from mutant
embryos demonstrated the dual origin of this structure: the PE-
derived layer was exclusively Β-GAL-positive, whereas the EPI-
derived mesodermal compartment was entirely GFP-positive
(Fig. 4F). As expected, yolk sacs of controls were chimeric in the
mesodermal compartment but not in the endoderm derived layer
(Fig 4J). Remarkably, all extra-embryonic tissues of the mutant
blastocyst-derived embryos were normal in size and shape and had to
be identiﬁed by PCR genotyping. This suggests that Nanog is
dispensable in extra-embryonic tissues, at least until E12.5, the latest
stage we analyzed.
Thus, the lethality of the Nanog-null mutation can be rescued by
providing a wt EPI, but Nanog-null cells themselves are still not
competent to contribute to the EPI. However, in the presence of a wt
EPI they can form all the extra-embryonic lineages derived from the
TE and PE, functional at least until mid-gestation.
Nanog functions in the blastocyst
Early lineage segregations in mouse embryonic development were
originally described as a succession of discrete, well ordered fate
decisions, driven by the antagonistic functions of lineage-speciﬁc
transcription factors (Fig. 5A) (Zernicka-Goetz et al., 2009). Only
recently has careful analysis of gene expression patterns in vivo
disclosed the dynamics and ﬂexibility of the decision-making processes
in the embryo and brought into question the mutual repression
proposed for the lineage-driving transcription factors (Dietrich and
Hiiragi, 2007; Plusa et al., 2008; Zernicka-Goetz et al., 2009). It appears
that themechanisms directing the formation of PE, TE and EPI are more
sophisticated and enmeshed than anticipated. For instance, new
evidence involves Nanog in a cross-regulation with Cdx2 (Chen et al.,
2009). However, we did not observe Cdx2 deregulation in our mutants,
thus this interaction may be subordinate in vivo.
The role of Nanog in PE formation
Since its ﬁrst description Nanog has been thought to prevent PE
differentiation, perhaps through interaction with a binding site in the
Fig. 4. (A) Scheme of blastocyst complementation experiments. (B) Section of an E7.5 embryo derived from ES cell-injection in a Nanog-deﬁcient blastocyst. ES/EPI-derived tissues
are LacZ-negative: extra-embryonic mesoderm (ExM), embryonic mesoderm (EmM) and embryonic ectoderm (EmE). Blastocyst-derived tissues are LacZ-positive: extra-embryonic
ectoderm (ExE) and endoderm of visceral yolk sac (VE). (C–J) Embryos derived from GFP-labeled ES cell-injection in mutant (C) and control (G) blastocysts. (D, H) GFP-detection in
embryos shown in (C) and (G), respectively. (E) IF detection of GFP (green) and β-GAL (red) on transversal sections through the hindbrain (HB) region from the embryo shown in (C,
section plane is indicated) (DAPI, blue; composite image of E' (GFP) and E" (β-GAL)). (I–I") Similar analysis for the control embryo shown in (G, section plane is indicated). Tissues
indicated are neural ectoderm (E) and mesoderm (M). (F, J) Sections of the visceral yolk sac of the embryos shown in (C) and (D) stained for GFP (green), β-GAL (red) and nuclei
(DAPI, blue). (Scale bars: 100 μm (B, E, I), 1 mm (C, D, G, H), 25 μm (F, J).
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Conversely, our data suggest that Nanog does not impede PE
differentiation in vivo, a fact also supported by the latest knock-out
studies in ES cells and embryos (Chambers et al., 2007; Silva et al.,
2009). But have Nanog-mutant ICM cells indeed lost the ability to
differentiate into PE (Silva et al. 2009)? We found they do give rise to
PE in blastocyst outgrowth experiments. However, in contrast to the
in vivo situation where PE formation is achieved within hours, in vitro
outgrowths require several days to attach and form the typicalmixture of TE, PE and EPI derivatives. This extended culture period
might be beneﬁcial to PE formation. We also found occasional Gata4
expression in E4.5 Nanog-null embryos, suggesting that some signal
required for PE induction must still be present in the mutant embryo.
It is therefore possible that TE-derived signals are beneﬁcial to PE
outgrowth when plating whole embryos, while in experiments using
ICMs only others merely observed TE-like derivatives (Silva et al.,
2009). Culture conditions, media composition and the time-point of
analysis could further inﬂuence Gata4 expression/detection.
Fig. 5. (A) Classical model of lineage decisions in the mouse pre-implantation embryo.
Mutually antagonistic acting lineage-speciﬁc transcription factors drive successive
differentiation events (TP, totipotent precursor). (B) Nanog is required cell autono-
mously for EPI induction but not for PE repression. (C) EPI cells are required non-cell
autonomously for PE formation, putatively by a combination of paracrine signaling and
cell–cell interaction.
136 D.M. Messerschmidt, R. Kemler / Developmental Biology 344 (2010) 129–137Compound interactions in the blastocyst
The upstreammechanisms leading to themosaic composition of the
ICM are as unknown as the processes involved in lineage restriction and
positional sorting of PE and EPI cells (reviewed in (Zernicka-Goetz et al.,
2009). Gata4 expression is dependent on Grb2–Ras–Map kinase
signaling and one potential upstream component in this pathway is
FGF4 (Chazaud et al., 2006). FGF4 as well as FGF4-receptor deletion
affects PE formation (Armanet al., 1998; Chai et al., 1998; Feldmanet al.,
1995). However, the role, source, and timing of FGF and other signaling
cascades are only beginning to be understood. Remarkably the
inhibition of FGF/Erk prevents Gata4 expression in the ICM of embryos
in vitro, resulting in the uniformly high expression levels of OCT4 and
NANOG in all ICM cells (Supplementary Fig. S3) (Nichols et al., 2009).
Once PE fate is induced however, FGF/Erk inhibition does not affect
Gata4 expression (Nichols et al., 2009). Our results are in complete
agreement with these ﬁndings, furthermore, they disclose the Nanog
expressing EPI as the primary source of the PE inducing signal.
We hypothesize that the loss of PE is the consequence of a non-
functional EPI, unable to provide the cues, e.g. a paracrine signal such as
FGF/Erk, required for promoting PE differentiation in neighboring ICM
cells. Thus, we suggest that Nanog promotes the EPI fate, but does not
prevent PE differentiation, in a cell autonomous manner (Fig. 5B).
During fate commitment, these future EPI cells instruct their surround-
ings to adopt a PE fate, if they are perceptive (Fig. 5C). The ability to
receive PE differentiation signals may again depend of Nanog/Oct4
expression levels (Chambers et al., 2007). The blastocyst complemen-
tation experiments clearly support this theory, as ES cell-derived EPIs
can rescue lethality and PE formation in a non-cell autonomousmanner
in Nanog-null blastocysts. Whereas the inhibition of FGF/Erk blocks PE
formation we were not able to induce Gata4 expression in Nanog
mutants in a reverse approach, by FGF-4 (maximal 150 ng/ml)
treatment. However, recent work by Yamanaka et al. published during
the preparation of this manuscript, showed that treatment of embryos
withveryhighdoses of FGF-4 (500 ng/ml) plusheparin is indeed able to
override the EPI-induction program resulting in 100% PE cells in the ICM
(Yamanaka et al. 2010). This new evidence further supports our
hypothesis of an EPI-derived PE inductive or promoting signal. Inconclusion, our careful analysis and manipulation of Nanog-deﬁcient
embryos reveals a new level of complexity in the processes that
determine early cell fates in themouse embryo and contributes a novel
feature to the complex picture of PE formation.
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